You just read:

Oncolytics Biotech® Inc.'s REOLYSIN® Provides Statistically Significant Improvement in Overall Survival in Canadian Cancer Trials Group Sponsored Randomized Phase 2 Study in Metastatic Breast Cancer

News provided by

Oncolytics Biotech Inc.

Mar 31, 2017, 16:23 ET